[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Osirium Technologies Plc LSE:OSI London Ordinary Share GB00BZ58DH10 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.50 -2.5% 19.50 50,543 09:52:05
Bid Price Offer Price High Price Low Price Open Price
19.00 20.00 20.00 19.25 20.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 1.43 -3.09 -13.00 5
Last Trade Time Trade Type Trade Size Trade Price Currency
13:26:10 O 375 19.01 GBX

Osirium Technologies (OSI) Latest News

More Osirium Technologies News
Osirium Technologies Investors    Osirium Technologies Takeover Rumours

Osirium Technologies (OSI) Discussions and Chat

Osirium Technologies Forums and Chat

Date Time Title Posts
17/10/202112:17The serious business of cybersecurity 379
16/10/200915:50Origo Sino-India19

Add a New Thread

Osirium Technologies (OSI) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Osirium Technologies trades in real-time

Osirium Technologies (OSI) Top Chat Posts

DateSubject
17/10/2021
09:20
Osirium Technologies Daily Update: Osirium Technologies Plc is listed in the Software & Computer Services sector of the London Stock Exchange with ticker OSI. The last closing price for Osirium Technologies was 20p.
Osirium Technologies Plc has a 4 week average price of 19p and a 12 week average price of 19p.
The 1 year high share price is 32.50p while the 1 year low share price is currently 17.50p.
There are currently 23,394,755 shares in issue and the average daily traded volume is 34,702 shares. The market capitalisation of Osirium Technologies Plc is £4,561,977.23.
08/10/2021
17:44
hedgehog 100: Definitely George, & you're welcome. Note that OSI's products have a range of patent protection, which represents both a powerful competitive barrier, and a very valuable asset. - "The intellectual property of Osirium includes 7 registered patents primarily in the 'Computing; Calculating' category, according to IPqwery." HTTP://www.crunchbase.com/organization/osirium/technology And in the period 2015-2020, OSI invested about £7.6M. into research and development, a sum greater than its current market cap. at 19.5p (££5.73M.) So it's taken a lot of time and money to develop OSI's products. Even if another company wanting such products were prepared to invest that much on R&D, and had the necessary skilled staff, they wouldn't have the time if they wanted to effectively exploit a market that is taking off right now. Add in the value of OSI's SAAS contracts, partnerships, and skilled staff, then its current takeover value could be multiples of its current level. Bearing in mind the high valuations in this sector, and the investor appetite for such stocks, then you with think that investors would be quite happy to fund such an acquisition. 11/06/2021 07:00 UKREG Osirium Technologies PLC Final Results "... The Group spent GBP1.81m (2019: GBP1.77m) on direct staff and contractor costs for research and development, of which all was capitalised in both periods. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/85337692 08/05/2019 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Final Results LSE:OSI Osirium Technologies Plc " ... The Group has also continued to increase its investment in R&D this past year. During this period, GBP1,439,119 has been capitalised, an increase of 15% from the previous year. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/79857494 24/04/2018 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Final Results LSE:OSI Osirium Technologies Plc " ... The Group has also continued to increase its investment in R&D this past year. During this period, GBP1,254,000 has been capitalised; an increase of 53% from the previous year. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/77243542 03/05/2017 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Final Results LSE:OSI Osirium Technologies Plc "... The Group continued to increase its investment in research and development, with GBP915,476 capitalised in the period (2015: GBP404,385), an increase of 126%. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/74484321
07/10/2021
16:07
hedgehog 100: In post 930 on my RTO thread I explain why a company's need to raise funds in the medium term can actually be a good thing. - Hedgehog 100 9 May '19 - 19:17 - 930 of 979 Edit 0 0 0 "Haydock, Yes, I'm expecting IQAI to raise additional funds in a few months. And I'm also expecting a period of very positive IQAI newsflow in the near future, driving the share price to much higher levels ahead of that fundraising. In fact, I would prefer a situation like this to one where a company doesn't need to raise funds for quite a while, and is happy to let the share price drift in the interim. IQAI did actually conduct a fundraising in March though, which bodes well for the price of the next fundraising. IQAI's March 2019 fundraising had two major positives: 1. The fundraising conversion price of 2p was at a massive premium (56.86%) to the then IQAI share price (1.275p). 2. The investment of the two CEO's was akin to massive directors share buying, a huge vote of confidence in the company, especially at such a massive premium. 11/03/2019 07:00 UKREG IQ-AI Limited Issue of Convertible Loan Notes "IQ-AI is pleased to announce that the Company has issued GBP268,500 in nominal amount of 6% unsecured convertible loan notes 2024, convertible into 13,425,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 2 pence per share ("CLNs"). The funds raised as a result of the issue of the CLNs will be used to provide additional working capital for the Company. The funds raised enables the Company to fully execute its current business plan and shareholders should take comfort that the Company is now able to fully execute its current strategic objectives, following this, initially, non-dilutive fundraise. Trevor Brown, Chairman of the Company, has subscribed for GBP250,000 of the CLNs and Michael Schmainda, Chief Executive Officer of the Company's 100% owned subsidiary, Imaging Biometrics LLC, has subscribed for GBP18,500 of the CLNs. ..." https://uk.advfn.com/stock-market/london/iq-ai-ltd-IQAI/share-news/IQ-AI-Limited-Issue-of-Convertible-Loan-Notes/79437794 There are some similarities with TERN near its medium term low of 2p. And TERN took advantage of its subsequent share price rise in 2018 to raise funds at far less dilution than otherwise - 08/05/2018 07:01 UK Regulatory (RNS & others) Tern PLC: Equity Fundraise Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that it has raised GBP1,750,000 before expenses through an unconditional placing of 9,459,460 new ordinary shares of 0.02p each at a price of 18.50 pence per ordinary share (the "Placing") with a single institutional investor, utilising the existing share authorities granted at the 2018 AGM. ... https://uk.advfn.com/stock-market/london/tern-TERN/share-news/Tern-PLC-Equity-Fundraise/77363922 25/07/2018 07:01 UK Regulatory (RNS & others) Tern PLC: Equity Fundraise of c. GBP2.9m Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that it has raised approximately GBP2.9 million before expenses through an unconditional placing of 11,192,307 new ordinary shares of 0.02p each at a price of 26 pence per ordinary share (the "Placing"), utilising the existing share authorities granted at the 2018 AGM. ... https://uk.advfn.com/stock-market/london/tern-TERN/share-news/Tern-PLC-Equity-Fundraise-of-c-GBP2-9m/77926992 " https://uk.advfn.com/cmn/fbb/thread.php3?id=31587598&from=930
29/9/2021
18:58
hedgehog 100: Edison are forecasting a strong second half for OSI, which should mean a series of contract wins RNSes. And at 22p, the OSI share price is at the same price as the April fundraising. O.K., the company is currently loss-making ... but they are tiny compared to many other tech companies, some without zero turnover, and OSI's last placing was completed in under a day, and at just a modest discount, investors were so keen for a piece of the action. With a surge in ransomware concerns this summer, this keenness will only have heightened. At this price though OSI is a sitting duck for a takeover, so anyone buying in at this price should be in a win-win situation.
15/9/2021
15:54
hedgehog 100: Last October OSI announced a contract for 5,000 endpoints (i.e. devices), compared to for e.g. contacts for 250 and 500 devices earlier in the year. Contract fees aren't revealed, but OSI's Fast Protect ransomware protection for backup systems is currently £4,995 for 10 devices protected for 3 years (additional devices available as an option). HTTP://www.osirium.com/osirium-fast-protect A contract for hundreds of times more devices than that would obviously be 'discounted' per device because of size, but still sounds like a big deal. So the fact that OSI is now capable of winning such larger contracts could potentially help to bring about a step change in revenues. OSI may also be increasingly seen as the 'go-to' specialist PAM provider for NHS trusts, judging from its contract wins over the last couple of years, and the company's statements. 20/02/2020 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Contract win with major regional NHS Trust LSE:OSI Osirium Technologies Plc "Contract win with major regional NHS Trust Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a contract win with one of the UK's largest regional NHS Trusts. The new client has purchased a 36 month term license for 500 devices, with Osirium delivering its PxM Platform including the Privileged Access Management, Privileged Task Management and Privileged Session Management modules . The PxM platform has been selected in a public sector tender bid against competing bids from two other Privileged Access Management solution providers to minimise the risk of security breaches in a mixed Windows and Cisco environment. Drivers for the implementation include securing and controlling access to the infrastructure by the 3(rd) party contractors, vendors and service providers on whom the Trust depends. The platform is also being used to enhance security by controlling and reducing the number of privileged accounts accessed by internal staff. David Guyatt, Chief Executive Officer, commented : "This brings another NHS Trust into our client roster and shows that Osirium is increasingly recognised as the PAM specialist best able to help these organisations address the security challenges they face. We see this as a further illustration of how NHS customers see us as strategic partners in strengthening the security of their IT operations."" https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Contract-win-with-major-r/81801447 17/03/2020 07:00 RNS Non-Regulatory Osirium Technologies PLC Contract win with major regional Ambulance Service LSE:OSI Osirium Technologies Plc "Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a contract win with a major regional UK Ambulance Service. The new client has purchased a 60 month term license for 250 devices for the Osirium PAM platform including the Privileged Access Management, Privileged Task Management and Privileged Session Management modules . Consultancy and training from Osirium Professional Services are included in the contract. The Osirium PAM platform has been selected in a public sector tender bid as part of a sales initiative led jointly by Osirium and an approved reseller partner. The principal d rivers for the client on this project are securing and controlling access to the infrastructure by 3(rd) party contractors and vendors, implementing secure access for internal staff to privileged accounts, and managing service accounts in line with policy. The client will be making full use of Osirium Task Automation to 'Shift Left' or delegate IT tasks to junior IT team members and free up senior IT staff to focus on complex projects. David Guyatt, Chief Executive Officer, commented : "I am delighted that, in addition to Osirium being selected as the specialist PAM provider for NHS Trusts, we and our reseller partners are now expanding our customer range to include the ambulance services sector. It is another illustration of the strength of Osirium functionality, in particular our task and process automation capabilities, combined with our UK presence and ease of deployment. These allow customers to automate key processes and securely delegate essential tasks in a way that drives real time and cost savings while ensuring maximum security."" https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Contract-win-with-major-r/82008548 15/10/2020 07:00 RNS Non-Regulatory Osirium Technologies PLC Contract win with leading healthcare provider LSE:OSI Osirium Technologies Plc "Competitive contract win for PAM and PEM solutions with leading healthcare provider Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a contract win with a leading provider of health services across the UK. The order was secured against competition from two other suppliers of Privileged Access Management ("PAM") technologies. The new customer has made a multi-product purchase including Osirium's PAM solution and 5,000 endpoints of Osirium's Privileged Endpoint Management ("PEM") platform. This combination provides them a complete solution from protecting privileged user accounts through to protecting privileges at the end-point level. Osirium's Professional Services team will assist with the implementation and rollout of both products as part of the contract. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Contract-win-with-leading/83462812
14/9/2021
12:33
hedgehog 100: It's interesting to compare OSI's latest 'outlook statement', from June of this year, with that from three years earlier. The latest outlook is subtly but significantly more bullish, including the phrases "exciting opportunities" and "vast opportunity ahead of us". The April 2018 outlook statement in comparison was confident, but more muted. The June statement also specifically mentions ransomware and home working, two trends that seem to be driving strong new OSI growth. Cybercrime has been described as the “number one problem with mankind” by Warren Buffett ... and who can argue with the 'Oracle of Omaha'? And OSI looks to me to have the most direct gearing to the ransomware menace of UK-listed cybersecurity stocks (not that there are that many). 24/04/2018 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Final Results LSE:OSI Osirium Technologies Plc " ... Summary and outlook Osirium has a unique proposition and is building an increasingly strong pipeline of opportunities across a broad range of corporate sectors. Since the year end, the funds raised in March 2018 will provide us with the capital to invest further in our sales, marketing, R&D and engineering teams to ensure the Group's momentum continues. As the global cyber-security market continues to grow and with General Data Protection Regulation (GDPR) on the horizon, Osirium is well positioned and is sufficiently differentiated to take advantage of this opportunity. The Group has built strong foundations for the year ahead and we are confident of delivering significant progress as a result. Simon Lee David Guyatt Chairman Chief Executive Officer ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/77243542 11/06/2021 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Final Results LSE:OSI Osirium Technologies Plc " ... Current trading and outlook Moving through 2021, we are seeing continued momentum with a record Q1 and a healthy pipeline of opportunities through our direct and indirect sales channels. While we remain vigilant to the ongoing economic uncertainty and risks to our end markets, we are encouraged by the gradual normalisation of trading conditions. Home working has laid bare many of the risks to cyber security among organisations, and many have made PAM a priority to ensure their company data, privileged accounts and regular business processes remain secure. The ease of implementation of the Group's platform and professionalism of customer engagement remains a key competitive advantages. Osirium provides the ideal solution for organisations wanting great quality security but without unnecessary complexity and protracted implementation. Healthcare, a key target market for the Group, continues to provide exciting opportunities, with a number of deals signed with providers in the public and private sectors during the period. In December 2020, NHS England announced funding for trusts via NHS Digital for PAM projects to protect backups targeted in ransomware attacks. In the first quarter of 2021 the Group secured a substantial number of new NHS accounts and will continue to capitalise on new opportunities in this sector. More widely, we continue to see strong demand across the public and private sectors for our services, with organisations valuing our ease of implementation and levels of customer support alongside our first-class technology. Post-period end, in April 2021, the Group also raised approximately GBP2.17m by way of a placing and subscription. These funds will facilitate the next phase of Osirium's growth primarily through scaling the Group's business in PAM and digital process automation, expanding the Group's partner channel network, and accelerating the Group's recruitment across sales, engineering and R&D. The Board would like to thank all shareholders for their continued support. Looking ahead, we expect the pandemic to continue to provide uncertainty throughout 2021 with respect to both our direct and indirect sales channels. While the exact timing of deals will remain difficult to predict in the near-term, market conditions are gradually improving, there is momentum in the business, and we have a clear and proven strategy to capitalise on the vast opportunity ahead of us. With privileged access now widely recognised as a core requirement of IT security, the Group is confident in its future prospects and another year of progress in 2021. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/85337692
13/9/2021
17:47
hedgehog 100: 11/06/2021 07:00 UKREG Osirium Technologies PLC Final Results " ... The Group spent GBP1.81m (2019: GBP1.77m) on direct staff and contractor costs for research and development, of which all was capitalised in both periods. This expenditure pertains to developing the Group's new and enhanced software offerings. The Group continues to invest in new product development, as well as the continual modification and improvement of its current product base to meet technological advances, customer and ever-expanding new market requirements of the rapidly evolving cybersecurity market. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/85337692 OSI's R&D investment is a major bull point here. OSI market capitalisation at the current share price of 25p: £7.35 million. Divided into OSI 2020 R&D spending of £1.81M. = PRR (price-to-research ratio) of 4.06. This highlights OSI's quite fantastic value and growth prospects. From the legendary tech stocks guru Conor McCarthy: "Calculate annual R & D expenditure per share and compare it to the share price. If the PRR (price-research ratio - share price divided by R and D per share) is 5 or less it is nearly always worth buying the shares. This applies particularly to recovery situations. As long as an exploration company has the wherewithal to drill holes, there is always the possibility it will strike it lucky. The same goes for an out-of-favour technology company. As long as it can continue to invest in R and D there is the chance it will come up with a blockbuster product. The lower the PRR the more development bang you get for your buck." HTTP://flylib.com/books/en/1.371.1.92/1/
13/9/2021
16:04
hedgehog 100: megasonic 13 Sep '21 - 15:38 - 290 of 290 0 1 0 " ... Sept 2020: 30p ..." No Megasonic, the OSI share price last September wasn't 30p. Here's the September 2020 OSI chart: the highest OSI closing share price was 23p, i.e. lower than the current 25p - Figures may not lie, but you do - repeatedly.
13/9/2021
14:48
hedgehog 100: Well you can read, can't you? There's two lies of yours exposed very clearly in my posts 284 and 285 above: 1. The OSI share price HASN'T been in free fall for three years. 2. OSI's revenues HAVEN'T only seen modest increases relative to companies like IGP etc. As regards OSI's spending, you've got to remember, over two fifths of OSI's admin. expenses are research & development spending: £1.81M. last year (up from £1.77M.), accounting for 42% of the admin. expenses of £4.3M. (down from £4.57M.) This impressive level of R&D spending is building up the company's valuable intellectual property, including multiple patents, so to criticise the company for not reducing it is crass. It's like criticising a biotech company for making losses, and I certainly wouldn't want OSI to reduce their R&D.
10/9/2021
14:22
hedgehog 100: Corrientes, Bizarre!! If OSI's products aren't modern enough, then why are its sales going through the roof, consistently winning contracts against its larger competitors? And if you don't think that OSI is investable, then why did you buy about £2K. of OSI shares last month? And if there's no interest, then why are you posting on this thread? That is a self-contradiction. I suppose you've sold for a gain of about 5% or so, and are now bashing it with silly b.s. in the hope of rebuying cheaper! And you can't even get the company's ticker right, calling it OMI rather than OSI!! 'Resting on its past laurels'? Are you blind?! The company's investment into R&D is striking, and its regular attendance at online industry events is notable. OSI's interim results are due his month, and will make clear just how well the company is doing. Astute investors have been buying in ahead of that, which is why the OSI share price is in a rising channel. Here's some technical analysis for the stock from SwingTradeBot: "Technical Analysis for IRON - Ironveld Plc" "ADX Long Term Intermediate Term Short Term Strong Up Up Flat" And from TradingView.com: "OSIRIUM TECHNOLOGIES PLC ORD 1P" "Technical analysis" "Oscillators Summary Moving Averages" "NEUTRAL BUY STRONG BUY" HTTP://uk.tradingview.com/symbols/LSE-OSI/technicals/
01/9/2021
17:47
hedgehog 100: Happydays, In the period 2015-2020, OSI invested about £7.6M. into research and development, a sum greater than its current market cap. at 24p (£7.05M.) So it's taken a lot of time and money to develop OSI's products. Even if another company wanting such products were prepared to invest that much on R&D, and had the necessary skilled staff, they wouldn't have the time if they wanted to effectively exploit a market that is taking off right now. Add in the value of OSI's SAAS contracts, partnerships, and skilled staff, then its current takeover value could be multiples of its current level. Bearing in mind the high valuations in this sector, and the investor appetite for such stocks, then you with think that investors would be quite happy to fund such an acquisition. 11/06/2021 07:00 UKREG Osirium Technologies PLC Final Results "... The Group spent GBP1.81m (2019: GBP1.77m) on direct staff and contractor costs for research and development, of which all was capitalised in both periods. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/85337692 08/05/2019 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Final Results LSE:OSI Osirium Technologies Plc " ... The Group has also continued to increase its investment in R&D this past year. During this period, GBP1,439,119 has been capitalised, an increase of 15% from the previous year. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/79857494 24/04/2018 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Final Results LSE:OSI Osirium Technologies Plc " ... The Group has also continued to increase its investment in R&D this past year. During this period, GBP1,254,000 has been capitalised; an increase of 53% from the previous year. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/77243542 03/05/2017 07:00 UK Regulatory (RNS & others) Osirium Technologies PLC Final Results LSE:OSI Osirium Technologies Plc "... The Group continued to increase its investment in research and development, with GBP915,476 capitalised in the period (2015: GBP404,385), an increase of 126%. ..." https://uk.advfn.com/stock-market/london/osirium-technologies-OSI/share-news/Osirium-Technologies-PLC-Final-Results/74484321
Osirium Technologies share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
OSI
Osirium Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211017 20:30:24